Literature DB >> 4949280

Rifampicin: a review.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4949280     DOI: 10.2165/00003495-197101050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  90 in total

1.  Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis.

Authors:  A Gyselen; L Verbist; J Cosemans; L M Lacquet; E Vandenbergh
Journal:  Am Rev Respir Dis       Date:  1968-12

2.  Clinical experience of the treatment of drug-resistant pulmonary tuberculosis with rifampicin combined with ethambutol and capreomycin.

Authors:  M Wäre; O Heinivaara; R Elo; E Tala
Journal:  Scand J Respir Dis Suppl       Date:  1969

3.  [Experimental study on rifamicin pharmacodynamics].

Authors:  G Curci; A Ninni; F Di Mezza
Journal:  Arch Tisiol Mal Appar Respir       Date:  1968-04

4.  [Preliminary observations on the therapeutic effect of rifampycin associated with streptomycin or isoniazid].

Authors:  G De Michele; F Iodice; B Lappa
Journal:  Arch Tisiol Mal Appar Respir       Date:  1968-05

5.  The action of rifampin alone and in combination with other antituberculous drugs.

Authors:  G L Hobby; T F Lenert
Journal:  Am Rev Respir Dis       Date:  1970-09

6.  Control clinical trial with rimactane in fresh, untreated cases of pulmonary tuberculosis.

Authors:  R Viswanathan; P U Rao; M Dusaj; D K Sarkar; U S Bhakta
Journal:  Indian J Med Res       Date:  1970-04       Impact factor: 2.375

7.  Rifampicin and poxvirus replication.

Authors:  Z Ben-Ishai; E Heller; N Goldblum; Y Becker
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

8.  Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state.

Authors:  L F Devine; D P Johnson; C R Hagerman; W E Pierce; S L Rhode; R O Peckinpaugh
Journal:  JAMA       Date:  1970-11-09       Impact factor: 56.272

9.  Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.

Authors:  A Vall-Spinosa; W Lester; T Moulding; P T Davidson; J K McClatchy
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

10.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.